[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335567-105":59,"doc-detail-335567-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dissecting-the-novel-molecular-interactions-of-solute-carrier-family-4-member-4-slc4a4-for-prostate-cancer-pca-progression","Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression","","Prostate cancer is a leading malignancy in men, and this study reports molecular pathways involving Homo sapiens solute carrier family 4 member 4 (SLC4A4) during progression of PCa. Findings from clinical prostatic acinar adenocarcinoma specimens show higher SLC4A4 expression in low-grade cases. Functional work links SLC4A4 to GSK-3β/β-catenin and RB signaling axes, where knockdown retards tumor growth and reduces invasion, migration, proliferation, and related metastatic behaviors. The results support SLC4A4 as a potential therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dissecting-the-novel-molecular-interactions-of-solute-carrier-family-4-member-4-slc4a4-for-prostate-cancer-pca-progression/335567/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dissecting-the-novel-molecular-interactions-of-solute-carrier-family-4-member-4-slc4a4-for-prostate-cancer-pca-progression/335567.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of this study on SLC4A4 in prostate cancer?","Question",{"text":112,"@type":113},"To report the molecular pathways involving SLC4A4 and how they modulate prostate cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SLC4A4 signaling affect PCa through the GSK-3β/β-catenin pathway?",{"text":117,"@type":113},"SLC4A4 influences phosphorylation events that relieve GSK-3β activity and alters β-catenin levels, impacting clonogenic potential, invasiveness, and metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens to tumor growth and cell behaviors when SLC4A4 is knocked down?",{"text":121,"@type":113},"SLC4A4 knockdown retards tumor growth and lowers invasion and migration potential, with reduced interactions in the RB-related mechanism and associated cell cycle arrest.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335567,1790194017,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression  \nAsif Rashid1,2*, Hiu Ling Fung1 & Alexander Hin Ning Tang1*  \nProstate cancer (PCa) is the most common malignancy diagnosed in men. The purpose of this study was to report the molecular pathways of Homo sapiens solute carrier family 4 member 4 (SLC4A4) in the progression of PCa. Here, we report our findings from clinical specimens of prostatic acinaradenocarcinoma collected from patients. We found that low-grade prostate cancers have higher SLC4A4 expression. We investigated the role ofSLC4A4 and the signaling mechanism underlying its role in modulating the PCa progression. Firstly, we reported the SLC4A4/GSK-3β/β-catenin signaling axis, which regulates the clonogenic potential, invasiveness, and metastasis. In this, we found reduced phosphorylation of GSK at serine 21 of α and serine 9 of the β subunit in shSLC4A4 cells of PCa, which ultimately relieved the activity of GSK-3β. This activated GSK-3β phosphorylates β-cateninat Ser33/37 with a subsequently reduced β-catenin level in PCa cells. Our functional analysis revealed that SLC4A4 knockdown retards tumor growth and lowers invasion and migration potential. Secondly, we investigated the SLC4A4/RB axis, which acts to drive cell proliferation. SLC4A4 knockdown decreases the interaction between these molecules with hypophosphorylation of RB protein and cell cycle arrest. Likewise, transcriptome sequencing using the SLC4A4 knockdown in DU145 cells regulates differentiated expressed genes and multiple metabolic pathways. Our results suggest that SLC4A4 may serve as a potential therapeutic target for prostate cancer patients in the future.  \nAbbreviations  \nPCa Prostate cancer  \nSLC4A4 Solute carrier family 4 member 4 RB Retinoblastoma-associated protein  \nPSA Prostate-specific antigen  \nGEPIA Gene expression profiling interactive analysis BPE Bovine pituitary extract  \nEGF Human recombinant epidermal growth factor SD Standard deviation  \nCHOL Cholangiocarcinoma  \nPRAD Prostate adenocarcinoma  \nPCPG Pheochromocytoma and paraganglioma  \nBLCA Bladder urothelial Carcinoma BRCA Breast cancer  \nCOAD Colon adenocarcinoma ESCA Esophageal Carcinoma  \nHNSC Head-neck squamous cell Carcinoma KICH Kidney chromophobe  \nKIRP Kidney renal papillary cell carcinoma LIHC Liver hepatocellular Carcinoma LUSC Lung squamous cell carcinoma  \n1Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China. 2Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. *email: arashid2@hku.hk; alextang@ pathology.hku.hk  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nREAD Rectum adenocarcinoma  \nSARC Sarcoma  \nTHCA Thyroid Cancer  \nCNV Copy number variation  \nEMEM Eagle’s minimum essential medium PBS Phosphate-buffered saline  \nFDR False discovery rate  \nProstate cancer (PCa) is the fifth-leading cause of death among men worldwide in 2020. The International Agency for Research on Cancer (IARC) released an updated Globocan 2020 with new estimates on the global cancer burden, indicating almost 1.4 million new cases and 375,000 deaths (3.8% of all male deaths caused by cancer) related to PCa1 and accounts for nearly 26% of all cancer cases2. Death rates for PCa are down 50% from their peak due to improvements in early detection, timely diagnosis and optimal treatment3.  \nHomo sapiens solute carrier family 4 member 4 (SLC4A4) is one of the differentially expressed genes encoding the electrogenic Na+/HCO3− cotransporter 1 (NBCe1) that moves HCO3-into cells and compensates intracellular H+ 4. SLC4A4 transporter is of particular interest in cancer research because it regulates the invasion, migration, and proliferation of cancer ","cbCaihATS9NDtm6u","https://ap.wps.com/l/cbCaihATS9NDtm6u","pdf",4021222,16,"English","# Molecular pathways of SLC4A4 in PCa\n## SLC4A4/GSK-3β/β-catenin axis\n## SLC4A4/RB axis and downstream effects\n## Clinical relevance and therapeutic implications","[{\"question\":\"What was the main purpose of this study on SLC4A4 in prostate cancer?\",\"answer\":\"To report the molecular pathways involving SLC4A4 and how they modulate prostate cancer progression.\"},{\"question\":\"How does SLC4A4 signaling affect PCa through the GSK-3β/β-catenin pathway?\",\"answer\":\"SLC4A4 influences phosphorylation events that relieve GSK-3β activity and alters β-catenin levels, impacting clonogenic potential, invasiveness, and metastasis.\"},{\"question\":\"What happens to tumor growth and cell behaviors when SLC4A4 is knocked down?\",\"answer\":\"SLC4A4 knockdown retards tumor growth and lowers invasion and migration potential, with reduced interactions in the RB-related mechanism and associated cell cycle arrest.\"}]","Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression | PDF",1790011456]